Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead
Roberta Ettari1, Lucia Tamborini, Ilenia C Angelo
1Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milano (Italy). roberta.ettari@unimi.it.
Abstract:
Novel rhodesain inhibitors were obtained by combining an enantiomerically pure 3-bromoisoxazoline warhead with a specific peptidomimetic recognition moiety. All derivatives behaved as inhibitors of rhodesain, with low micromolar Ki values. Their activity against the enzyme was found to be paralleled by an in vitro antitrypanosomal activity, with IC50 values in the mid-micromolar range. Notably, a preference for parasitic over human proteases, specifically cathepsins B and L, was observed.
Related Concept Videos
Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation
Radical Anti-Markovnikov Addition to Alkenes: Overview
ortho–para-Directing Deactivators: Halogens
Regioselectivity of Electrophilic Additions-Peroxide Effect
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Radical Substitution: Allylic Bromination


![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)